Abstract
Beside molecules produced by classical organic synthesis, by combinatorial chemistry or designed by molecular modeling, natural products represent a large source of new chemical entities, potential lead compounds or novel drugs. These compounds originate from higher plants, marine organisms, fungi and animals, or are produced by microorganisms or yeasts using biotechnology. This chapter will focus on secondary metabolites from higher plants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boonen G, Häberlein H (1998) Influence of genuine kavapyrone enantiomers on the GABA-A binding site. Planta Med 64:504–506
Boonen G, Ferger B, Kuschinsky K, Häberlein H (1998) In vivo effects of the kavapyrones (+)-dihydromethysticin and (+/-)-kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions. Planta Med 64:507–510
Boonen G, Pramanik A, Rigler R, Häberlein H (2000) Evidence for specific interactions between kavain and human cortical neurons monitored by fluorescence correlation spectroscopy. Planta Med 66:7–10
Burkhard PR, Burkhardt K, Haenggeli CA, Landis T (1999) Plant-induced seizures: reappearance of an old problem. J Neurol 246:667–670
Connor J, Makonnen E, Rostom A (2000) Comparison of analgesic effects of khat (Catha edulis Forsk.) extract, D-amphetamine and ibuprofen in mice. J Pharm Pharmacol 52:107–110
Croteau R, Gershenzon J, Wheeler CJ, Satterwhite DM (1990) Biosynthesis of monoterpenes: stereochemistry of the coupled isomerization and cyclization of geranyl pyrophosphate to camphane and isocamphane monoterpenes. Arch Biochem Biophys 277:374–381
CSPV (2000) Atteintes hépatiques liées aux extraits de kawa. J Suisse Pharm 138: 437–438
Davies LP, Drew CA, Duffield P, Johnston GA, Jamieson DD (1992) Kava pyrones and resin: studies on GABA-A, GABA-B and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 71:120–126
Dräger B (1996) Wie kommt Atropin in die Tollkirsche? Neues zur Regulation des pflanzlichen Sekundärstoffwechsels. Pharm Uns Zeit 25:242–249
Eccles R (1994) Menthol and related cooling compounds. J Pharm Pharmacol 46:618–630
Francis PD, Clarke CF (1999) Angel trumpet lily poisoning in five adolescents: clinical findings and management. J Paediatr Child Health 35:93–95
Häberlein H, Boonen G, Beck M-A (1997) Piper methysticum: enantiomeric separation of kavapyrones by high performance liquid chromatography. Planta Med 63:63–65
Halket JM, Karasu Z, Murray-Lyon IM (1995) Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk). J Ethnopharmacol 49:111–113
Hansel R, Sticher O, Steinegger E (1999) Pharmakognosie—Phytopharmazie. Springer, Berlin
Holm E, Staedt U, Heep J, Kortsik C, Behne F, Kaske A, Mennicke I (1991) The action profile of D,L-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals. Arzneim-Forsch / Drug Res 41:673–683
Hostettmann K, Potterat O, Wolfender J-L (1998) The potential of higher plants as a source of new drugs. Chimia 52:10–17
Jamali F, Mehvar R, Pasutto FM (1989) Enantioselective aspects of drug action and disposition: therapeutic pitfalls. J Pharm Sei 78:695–715
Kalix P (1996) Catha edulis, a plant that has amphetamine effects. Pharm World Sci 18:69–73
Leitereg TJ, Guadagni DG, Harris J, Mon TR,T eranishi R (1971) Evidence for the difference between the odours of the optical isomers (+)-and (-)-carvone. Nature 230:455–456
Liaudet L, Buclin T, Jaccard C, Eckert P (1999) Drug points: severe ergotism associated with interaction between ritonavir and ergotamine. BMJ 318:771
Mann J (1992) Murder, Magic and Medicine. Oxford University Press, Oxford, UK
Nunes MA, Brochmann-Hanssen E (1974) Hydrolysis and epimerization kinetics of pilocarpine in aqueous solution. J Pharm Sci 63:716–721
Pallenbach E (1996) Die Männer mit der dicken Backe. Khat im Jemen. Dtsch Apoth Ztg 136:3399–3410
Rang HP, Ritter JM, Dale MM (1995) Pharmacology. Churchill Livingstone, Edinburgh
Rauber C, Guirguis M, Meier-Abt AS, Gossweiler B, Meier PJ (1999) Lethal poisoning after ingestion of a tea prepared from the angel’s trumpet (Datura suaveolens). XIX International Congress, EAPCCT, Dublin, Eire, June 22–25
Ravid U, Putievsky E, Katzir I (1993) Determination of the enantiomeric composition of (1R) (+)-and (IS) (-)-camphor in essential oils of some Lamiaceae and Compositae herbs. Flav Fragr J 8:225–228
Reist M, Testa B, Carrupt P-A, Jung M, Schurig V (1995) Racemization, enantiomerization, diastereomerization, and epimerization: their meaning and pharmacological significance. Chirality 7:396–400
Shelley MD, Hartley L, Fish RG, Groundwater P, Morgan JJ, Mort D, Mason M, Evans A (1999) Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines. Cancer Lett 135:171–180
Singh YN (1992) Kava: an overview. J Ethnopharmacol 37:13–45
Szepesi G, Gazdag M, Ivancsics R, Mihalyfi K, Kovacs P (1983) Investigation of degradation mechanism of pilocarpine by HPLC. Pharmazie 38:94–98
Testa B, Carrupt PA, Gal J (1993) The so-called “interconversion” of stereoisomeric drugs: an attempt at clarification. Chirality 5:105–111
Volz H-P, Kieser M (1997) Kava-kava extract WS 1490 versus placebo in anxiety disorders—a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 30:1–5
Wu YW (1987) Probing into the mechanism of action, metabolism and toxicity of gossypol by studying its (+)-and (-)-stereoisomers. J Ethnopharmacol 20:65–78
Wu D (1989) An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease. Drugs 38: 333–341
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Terreaux, C., Hostettmann, K. (2003). Stereochemical Issues in Bioactive Natural Products. In: Eichelbaum, M., Testa, B., Somogyi, A. (eds) Stereochemical Aspects of Drug Action and Disposition. Handbook of Experimental Pharmacology, vol 153. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55842-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-55842-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62575-6
Online ISBN: 978-3-642-55842-9
eBook Packages: Springer Book Archive